AAAAAA
Results: 1-25/33
Authors:
Arima, H
Kihara, F
Hirayama, F
Uekama, K
Citation: H. Arima et al., Enhancement of gene expression by polyamidoamine dendrimer conjugates withalpha-, beta-, and gamma-cyclodextrins, BIOCONJ CHE, 12(4), 2001, pp. 476-484
Authors:
Ono, N
Arima, H
Hirayama, F
Uekama, K
Citation: N. Ono et al., A moderate interaction of maltosyl-alpha-cyclodextrin with Caco-2 cells incomparison with the parent cyclodextrin, BIOL PHAR B, 24(4), 2001, pp. 395-402
Authors:
Arima, H
Nishimoto, Y
Motoyama, K
Hirayama, F
Uekama, K
Citation: H. Arima et al., Inhibitory effects of novel hydrophilic cyclodextrin derivatives on nitricoxide production in macrophages stimulated with lipopolysaccharide, PHARM RES, 18(8), 2001, pp. 1167-1173
Authors:
Uekama, K
Hieda, Y
Hirayama, F
Arima, H
Sudoh, M
Yagi, A
Terashima, H
Citation: K. Uekama et al., Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrinon prostaglandin E-1 analogue, PHARM RES, 18(11), 2001, pp. 1578-1585
Authors:
Nagase, Y
Hirata, M
Wada, K
Arima, H
Hirayama, F
Irie, T
Kikuchi, M
Uekama, K
Citation: Y. Nagase et al., Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin, INT J PHARM, 229(1-2), 2001, pp. 163-172
Authors:
Hirayama, F
Zaoh, K
Harata, K
Saenger, W
Uekama, K
Citation: F. Hirayama et al., Transparent, adhesive film formation of per-O-valeryl-beta-cyclodextrin, CHEM LETT, (7), 2001, pp. 636-637
Authors:
Arima, H
Yunomae, K
Hirayama, F
Uekama, K
Citation: H. Arima et al., Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus (vol 297, pg 547, 2001), J PHARM EXP, 298(1), 2001, pp. 392-392
Authors:
Arimoa, H
Yunomae, K
Hirayama, F
Uekama, K
Citation: H. Arimoa et al., Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus, J PHARM EXP, 297(2), 2001, pp. 547-555
Authors:
Arima, H
Yunomae, K
Miyake, K
Irie, T
Hirayama, F
Uekama, K
Citation: H. Arima et al., Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats, J PHARM SCI, 90(6), 2001, pp. 690-701
Authors:
Yano, H
Hirayama, F
Arima, H
Uekama, K
Citation: H. Yano et al., Preparation of prednisolone-appended alpha-, beta- and gamma-cyclodextrins: Substitution at secondary hydroxyl groups and in vitro hydrolysis behavior, J PHARM SCI, 90(4), 2001, pp. 493-503
Authors:
Ono, N
Hirayama, F
Arima, H
Uekama, K
Citation: N. Ono et al., Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexation, CHEM PHARM, 49(1), 2001, pp. 78-81
Authors:
Anibarro, M
Gessler, K
Uson, I
Sheldrick, GM
Harata, K
Uekama, K
Hirayama, F
Abe, Y
Saenger, W
Citation: M. Anibarro et al., Effect of peracylation of beta-cyclodextrin on the molecular structure andon the formation of inclusion complexes: An X-ray study, J AM CHEM S, 123(48), 2001, pp. 11854-11862
Authors:
Hirayama, F
Honjo, M
Arima, H
Okimoto, K
Uekama, K
Citation: F. Hirayama et al., X-ray crystallographic characterization of nilvadipine monohydrate and itsphase transition behavior, EUR J PH SC, 11(1), 2000, pp. 81-88
Authors:
Ikeda, Y
Kimura, K
Hirayama, F
Arima, H
Uekama, K
Citation: Y. Ikeda et al., Controlled release of a water-soluble drug, captopril, by a combination ofhydrophilic and hydrophobic cyclodextrin derivatives, J CONTR REL, 66(2-3), 2000, pp. 271-280
Authors:
Tokihiro, K
Arima, H
Tajiri, S
Irie, T
Hirayama, F
Uekama, K
Citation: K. Tokihiro et al., Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats, J PHARM PHA, 52(8), 2000, pp. 911-917
Authors:
Hirayama, F
Ogata, T
Yano, H
Arima, H
Udo, K
Takano, M
Uekama, K
Citation: F. Hirayama et al., Release characteristics of a short-chain fatty acid, n-butyric acid, from its beta-cyclodextrin ester conjugate in rat biological media, J PHARM SCI, 89(11), 2000, pp. 1486-1495
Authors:
Yamada, T
Imai, T
Ouchi, K
Otagiri, M
Hirayama, F
Uekama, K
Citation: T. Yamada et al., Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin:Interaction and dissolution properties, CHEM PHARM, 48(9), 2000, pp. 1264-1269
Authors:
Yano, H
Hirayama, F
Arima, H
Uekama, K
Citation: H. Yano et al., Hydrolysis behavior of prednisolone 21-hemisuccinate/beta-cyclodextrin amide conjugate: Involvement of intramolecular catalysis of amide group in drug release, CHEM PHARM, 48(8), 2000, pp. 1125-1128
Authors:
Kimura, K
Hirayama, F
Arima, H
Uekama, K
Citation: K. Kimura et al., Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex, CHEM PHARM, 48(5), 2000, pp. 646-650
Authors:
Harata, K
Hirayama, H
Uekama, K
Citation: K. Harata et al., Crystal structures of heptakis(2,6-di-O-ethyl)cyclomaltoheptaose [heptakis(2,6-di-O-ethyl)-beta-cyclodextrin]. Solvent-regulated helical assembly of macrocycles, CARBOHY RES, 329(3), 2000, pp. 597-607
Authors:
Ono, N
Hirayama, F
Arima, H
Uekama, K
Citation: N. Ono et al., Determination of stability constant of beta-cyclodextrin complexes using the membrane permeation technique and the permeation behavior of drug-competing agent-beta-cyclodextrin ternary systems, EUR J PH SC, 8(2), 1999, pp. 133-139
Authors:
Miyake, K
Arima, H
Irie, T
Hirayama, F
Uekama, K
Citation: K. Miyake et al., Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats, BIOL PHAR B, 22(1), 1999, pp. 66-72
Authors:
Okimoto, K
Ohike, A
Ibuki, R
Aoki, O
Ohnishi, N
Irie, T
Uekama, K
Rajewski, RA
Stella, VJ
Citation: K. Okimoto et al., Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)(7m)-beta-CD, PHARM RES, 16(4), 1999, pp. 549-554
Authors:
Kimura, K
Hirayama, F
Arima, H
Uekama, K
Citation: K. Kimura et al., Solid-state C-13 nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins, PHARM RES, 16(11), 1999, pp. 1729-1734
Authors:
Miyake, K
Irie, T
Arima, H
Hirayama, F
Uekama, K
Hirano, M
Okamoto, Y
Citation: K. Miyake et al., Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution, INT J PHARM, 179(2), 1999, pp. 237-245